Ralph Schiess
Directeur Général chez ONCONETIX, INC.
Fortune : 55 568 $ au 31/05/2024
Postes actifs de Ralph Schiess
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ONCONETIX, INC. | Directeur Général | 12/01/2024 | - |
| Directeur Technique/Scientifique/R&D | 15/12/2023 | - | |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Directeur Général | 01/01/2010 | - |
| Fondateur | 01/01/2010 | - | |
| Directeur/Membre du Conseil | 01/01/2010 | 01/01/2020 | |
| Directeur Technique/Scientifique/R&D | 01/01/2020 | 01/05/2023 |
Historique de carrière de Ralph Schiess
Formation de Ralph Schiess
| University of Zurich | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistiques
Internationale
| Suisse | 3 |
| Allemagne | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Bourse
- Insiders
- Ralph Schiess
- Expérience
